Clinical trial
Short-Term Effects of the FX-Class of Haemodialyser on Quality of Life and Inflammatory Markers in Stable Dialysis Patients
NCT00291603 is registered in ClinicalTrials.gov with Sir Charles Gairdner Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Short-Term Effects of the FX-Class of Haemodialyser on Quality of Life and Inflammatory Markers in Stable Dialysis Patients
- Lead sponsor
- Sir Charles Gairdner Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- December 31, 2006
- Enrollment
- 50
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.